Iloprost

• 

  Subject Areas on Research

  • Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension. 
  • Combined tissue-type plasminogen activator and prostacyclin therapy for acute myocardial infarction. Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) 4 Study Group. 
  • Iloprost in alginate decreases the thrombogenicity of expanded polytetrafluoroethylene. 
  • Inhaled Iloprost Versus Epoprostenol in Heart Transplant Recipients. 
  • New treatment approaches for osteonecrosis of the femoral head: an overview. 
  • The Influence of Topical Vasodilator-Induced Pharmacologic Delay on Cutaneous Flap Viability and Vascular Remodeling.